Metraipolis › archive › dc_ed540ab24f74

Diagnosis-Driven Targeted Therapy in Acute Myeloid Leukemia: Clinical Integration of Tyrosine Kinase, BCL-2, and CD33-Directed Strategies with Midostaurin,… — Europe PMC PMID:42452347

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42452347
DOI
10.3390/jcm15134886
License (as archived)
solo-consultazione
Archived
2026-10-19T05:55:51.058Z
SHA-256 of the archived text
8a57b1a4f99889a87aba4993a8113e79d0cfcdfc20b56988a46ce2ddf2c691b9
Stable URL of this page
https://metraipolis.com/documento/dc_ed540ab24f74

How to cite

Diagnosis-Driven Targeted Therapy in Acute Myeloid Leukemia: Clinical Integration of Tyrosine Kinase, BCL-2, and CD33-Directed Strategies with Midostaurin,… — Europe PMC PMID:42452347 — Europe PMC (en), https://europepmc.org/article/MED/42452347 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed540ab24f74 (Metraipolis archive dc_ed540ab24f74, sha256 8a57b1a4f99889a87aba4993a8113e79d0cfcdfc20b56988a46ce2ddf2c691b9)
BibTeX
@misc{dced540ab24f74,
  title = {Diagnosis-Driven Targeted Therapy in Acute Myeloid Leukemia: Clinical Integration of Tyrosine Kinase, BCL-2, and CD33-Directed Strategies with Midostaurin,… — Europe PMC PMID:42452347},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42452347},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed540ab24f74; sha256 8a57b1a4f99889a87aba4993a8113e79d0cfcdfc20b56988a46ce2ddf2c691b9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42452347. Agents can read the archived copy with the MCP tool read_document.